DrugPatentWatch Database Preview
Nextwave Pharms Company Profile
» See Plans and Pricing
What is the competitive landscape for NEXTWAVE PHARMS, and what generic alternatives to NEXTWAVE PHARMS drugs are available?
NEXTWAVE PHARMS has one approved drug.
There are six US patents protecting NEXTWAVE PHARMS drugs.
There are thirty-four patent family members on NEXTWAVE PHARMS drugs in fourteen countries.
Summary for Nextwave Pharms
| International Patents: | 34 |
| US Patents: | 6 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Nextwave Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nextwave Pharms | QUILLICHEW ER | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE, CHEWABLE;ORAL | 207960-002 | Dec 4, 2015 | RX | Yes | No | 8,202,537 | Start Trial | Y | Start Trial | |||
| Nextwave Pharms | QUILLICHEW ER | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE, CHEWABLE;ORAL | 207960-003 | Dec 4, 2015 | RX | Yes | Yes | 9,844,544 | Start Trial | Y | Start Trial | |||
| Nextwave Pharms | QUILLICHEW ER | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE, CHEWABLE;ORAL | 207960-002 | Dec 4, 2015 | RX | Yes | No | 8,999,386 | Start Trial | Y | Start Trial | |||
| Nextwave Pharms | QUILLICHEW ER | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE, CHEWABLE;ORAL | 207960-001 | Dec 4, 2015 | RX | Yes | No | 8,202,537 | Start Trial | Y | Start Trial | |||
| Nextwave Pharms | QUILLICHEW ER | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE, CHEWABLE;ORAL | 207960-001 | Dec 4, 2015 | RX | Yes | No | 9,295,642 | Start Trial | Y | Start Trial | |||
| Nextwave Pharms | QUILLICHEW ER | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE, CHEWABLE;ORAL | 207960-002 | Dec 4, 2015 | RX | Yes | No | 8,287,903 | Start Trial | Y | Start Trial | |||
| Nextwave Pharms | QUILLICHEW ER | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE, CHEWABLE;ORAL | 207960-001 | Dec 4, 2015 | RX | Yes | No | 8,999,386 | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Nextwave Pharms Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Denmark | 2018160 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2012112140 | Start Trial |
| China | 102488652 | Start Trial |
| Canada | 2645855 | Start Trial |
| Denmark | 2884961 | Start Trial |
| Austria | 536867 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2014028610 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
